Jianerkang Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	984.19	1,042	1,032	1,090	780.16	1,615
Other Revenue	4.02	4.02	1.4	2.77	1.88	8.5
Revenue	988.21	1,046	1,034	1,093	782.04	1,623
Revenue Growth (YoY)	-10.58%	1.18%	-5.46%	39.79%	-51.83%	116.77%
Cost of Revenue	757.86	812.39	802.61	834.8	600.08	881.01
Gross Profit	230.35	233.37	230.92	258.43	181.97	742.47
Selling, General & Admin	73.13	62.87	54.31	57.13	51.42	101.57
Research & Development	39.2	40.72	36.59	35.3	28.64	51
Other Operating Expenses	12.35	9.62	7.89	9.09	6.43	11.46
Operating Expenses	128.23	112.73	104.73	116.07	80.98	154.99
Operating Income	102.12	120.64	126.18	142.36	100.98	587.48
Interest Expense	-0.76	-0.01	-0.65	-1.66	-2.07	-11.76
Interest & Investment Income	12.32	7.61	4.35	2.67	0.45	4.22
Currency Exchange Gain (Loss)	6.29	6.29	8.67	28.55	-7.17	-19.75
Other Non Operating Income (Expenses)	-4.37	-0.2	-0.25	-0.23	-0.45	-0.56
EBT Excluding Unusual Items	115.6	134.34	138.31	171.69	91.74	559.64
Gain (Loss) on Sale of Investments	0.31	-	-16.68	-	-	-
Gain (Loss) on Sale of Assets	0.25	0.43	0.03	-3.02	0.13	0
Asset Writedown	-4.92	-0.07	-0.07	-0.07	-0.12	-37.72
Other Unusual Items	6.42	2.78	20.68	9.24	57.88	4.98
Pretax Income	117.87	137.69	142.62	177.83	149.63	526.9
Income Tax Expense	14.7	17.48	19.08	20.49	18	142.64
Net Income	103.17	120.22	123.55	157.34	131.63	384.26
Net Income to Common	103.17	120.22	123.55	157.34	131.63	384.26
Net Income Growth	-22.78%	-2.69%	-21.48%	19.53%	-65.75%	457.65%
Shares Outstanding (Basic)	152	123	117	117	117	104
Shares Outstanding (Diluted)	152	123	117	117	117	104
Shares Change (YoY)	30.14%	4.97%	0.21%	-0.01%	12.43%	9.21%
EPS (Basic)	0.68	0.98	1.05	1.34	1.13	3.69
EPS (Diluted)	0.68	0.98	1.05	1.34	1.13	3.69
EPS Growth	-40.66%	-7.30%	-21.64%	19.54%	-69.53%	410.62%
Free Cash Flow	80.1	101.35	73.62	96.7	21.96	370.05
Free Cash Flow Per Share	0.53	0.82	0.63	0.83	0.19	3.56
Dividend Per Share	0.270	0.270	-	-	-	-
Gross Margin	23.31%	22.32%	22.34%	23.64%	23.27%	45.73%
Operating Margin	10.33%	11.54%	12.21%	13.02%	12.91%	36.19%
Profit Margin	10.44%	11.50%	11.95%	14.39%	16.83%	23.67%
Free Cash Flow Margin	8.11%	9.69%	7.12%	8.85%	2.81%	22.79%
EBITDA	145.77	163.13	167.13	179.2	133.4	594.06
EBITDA Margin	14.75%	15.60%	16.17%	16.39%	17.06%	36.59%
D&A For EBITDA	43.65	42.49	40.95	36.84	32.41	6.59
EBIT	102.12	120.64	126.18	142.36	100.98	587.48
EBIT Margin	10.33%	11.54%	12.21%	13.02%	12.91%	36.19%
Effective Tax Rate	12.47%	12.69%	13.38%	11.52%	12.03%	27.07%
Revenue as Reported	988.21	1,046	1,034	1,093	782.04	1,623
Advertising Expenses	-	3.14	2.16	2.84	3.15	1.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.